- Home
- SYM vs CPRX Comparison
SYM vs CPRX Comparison
Compare SYM & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYM
- CPRX
- Stock Information
- Founded
- SYM 2005
- CPRX 2002
- Country
- SYM United States
- CPRX United States
- Employees
- SYM N/A
- CPRX N/A
- Industry
- SYM Industrial Machinery/Components
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- SYM Industrials
- CPRX Health Care
- Exchange
- SYM Nasdaq
- CPRX Nasdaq
- Market Cap
- SYM 3.0B
- CPRX 2.5B
- IPO Year
- SYM N/A
- CPRX 2006
- Fundamental
- Price
- SYM $29.76
- CPRX $22.78
- Analyst Decision
- SYM Buy
- CPRX Strong Buy
- Analyst Count
- SYM 16
- CPRX 7
- Target Price
- SYM $40.13
- CPRX $32.86
- AVG Volume (30 Days)
- SYM 2.3M
- CPRX 1.4M
- Earning Date
- SYM 02-03-2025
- CPRX 02-26-2025
- Dividend Yield
- SYM N/A
- CPRX N/A
- EPS Growth
- SYM N/A
- CPRX 114.68
- EPS
- SYM N/A
- CPRX 1.18
- Revenue
- SYM $1,788,179,000.00
- CPRX $460,482,000.00
- Revenue This Year
- SYM $30.80
- CPRX $23.98
- Revenue Next Year
- SYM $29.33
- CPRX $18.27
- P/E Ratio
- SYM N/A
- CPRX $19.33
- Revenue Growth
- SYM 51.94
- CPRX 32.17
- 52 Week Low
- SYM $17.11
- CPRX $13.12
- 52 Week High
- SYM $52.20
- CPRX $24.27
- Technical
- Relative Strength Index (RSI)
- SYM 58.17
- CPRX 56.81
- Support Level
- SYM $23.66
- CPRX $21.23
- Resistance Level
- SYM $33.36
- CPRX $23.26
- Average True Range (ATR)
- SYM 1.84
- CPRX 1.14
- MACD
- SYM 0.76
- CPRX 0.20
- Stochastic Oscillator
- SYM 64.53
- CPRX 74.85
About SYM Symbotic Inc.
Symbotic Inc is an automation technology company that develops technologies to improve operating efficiencies in modern warehouses. The group develops, commercializes, and deploys innovative, end-to-end technology solutions that dramatically improve supply chain operations. Symbotic also automates the processing of pallets and cases in large warehouses or distribution centers for some of the retail and wholesale companies in the world. The company operates in two geographical regions the United States and Canada. Key revenue is generated from the United States.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.